Literature DB >> 29431637

Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells.

Tonya C Walser1,2,3, Zhe Jing1,2,3, Linh M Tran1,2,3, Ying Q Lin1,2,3, Natalie Yakobian1,2,3, Gerald Wang1,2,3, Kostyantyn Krysan1,2,3, Li X Zhu1,2,3,4, Sherven Sharma1,2,3,4, Mi-Heon Lee5, John A Belperio1,2,3, Aik T Ooi3,6,7, Brigitte N Gomperts3,6,7, Jerry W Shay8, Jill E Larsen9, John D Minna10, Long-Sheng Hong11, Michael C Fishbein11, Steven M Dubinett12,2,3,4,11,13.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is organized in cancer cells by a set of key transcription factors, but the significance of this process is still debated, including in non-small cell lung cancer (NSCLC). Here, we report increased expression of the EMT-inducing transcription factor Snail in premalignant pulmonary lesions, relative to histologically normal pulmonary epithelium. In immortalized human pulmonary epithelial cells and isogenic derivatives, we documented Snail-dependent anchorage-independent growth in vitro and primary tumor growth and metastatic behavior in vivo Snail-mediated transformation relied upon silencing of the tumor-suppressive RNA splicing regulatory protein ESRP1. In clinical specimens of NSCLC, ESRP1 loss was documented in Snail-expressing premalignant pulmonary lesions. Mechanistic investigations showed that Snail drives malignant progression in an ALDH+CD44+CD24- pulmonary stem cell subset in which ESRP1 and stemness-repressing microRNAs are inhibited. Collectively, our results show how ESRP1 loss is a critical event in lung carcinogenesis, and they identify new candidate directions for targeted therapy of NSCLC.Significance: This study defines a Snail-ESRP1 cancer axis that is crucial for human lung carcinogenesis, with implications for new intervention strategies and translational opportunities. Cancer Res; 78(8); 1986-99. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29431637      PMCID: PMC5899686          DOI: 10.1158/0008-5472.CAN-17-0315

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis.

Authors:  Jeanette L Grant; Michael C Fishbein; Long-Sheng Hong; Kostyantyn Krysan; John D Minna; Jerry W Shay; Tonya C Walser; Steven M Dubinett
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-19

4.  Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer.

Authors:  Xiaomin Zhong; Lan Zheng; Jianfeng Shen; Dongmei Zhang; Minmin Xiong; Youyou Zhang; Xinhong He; Janos L Tanyi; Feng Yang; Kathleen T Montone; Xiaojun Chen; Congjian Xu; Andy P Xiang; Qihong Huang; Xiaowei Xu; Lin Zhang
Journal:  Mol Cell Biol       Date:  2016-10-13       Impact factor: 4.272

5.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.

Authors:  Ulrich Wellner; Jörg Schubert; Ulrike C Burk; Otto Schmalhofer; Feng Zhu; Annika Sonntag; Bettina Waldvogel; Corinne Vannier; Douglas Darling; Axel zur Hausen; Valerie G Brunton; Jennifer Morton; Owen Sansom; Julia Schüler; Marc P Stemmler; Christoph Herzberger; Ulrich Hopt; Tobias Keck; Simone Brabletz; Thomas Brabletz
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

6.  ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.

Authors:  Jill E Larsen; Vaishnavi Nathan; Jihan K Osborne; Rebecca K Farrow; Dhruba Deb; James P Sullivan; Patrick D Dospoy; Alexander Augustyn; Suzie K Hight; Mitsuo Sato; Luc Girard; Carmen Behrens; Ignacio I Wistuba; Adi F Gazdar; Nicholas K Hayward; John D Minna
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

7.  Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

Authors:  Mitsuo Sato; Melville B Vaughan; Luc Girard; Michael Peyton; Woochang Lee; David S Shames; Ruben D Ramirez; Noriaki Sunaga; Adi F Gazdar; Jerry W Shay; John D Minna
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

8.  Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function.

Authors:  Sun-Hye Lee; Su-Jin Lee; Yeon Sang Jung; Yongbin Xu; Ho Sung Kang; Nam-Chul Ha; Bum-Joon Park
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

9.  Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells.

Authors:  Chie Kudo-Saito; Hiromi Shirako; Tadashi Takeuchi; Yutaka Kawakami
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

10.  Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1.

Authors:  Claudia Voena; Lydia M Varesio; Liye Zhang; Matteo Menotti; Teresa Poggio; Elena Panizza; Qi Wang; Valerio G Minero; Sharmila Fagoonee; Mara Compagno; Fiorella Altruda; Stefano Monti; Roberto Chiarle
Journal:  Oncotarget       Date:  2016-05-31
View more
  5 in total

1.  APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells.

Authors:  Maree C Faux; Lauren E King; Serena R Kane; Christopher Love; Oliver M Sieber; Antony W Burgess
Journal:  Mol Biol Cell       Date:  2020-11-25       Impact factor: 4.138

2.  Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling.

Authors:  Weimei Huang; Yunchu Yang; Jingfang Wu; Yuchun Niu; Yao Yao; Jian Zhang; Xiaoxian Huang; Shumei Liang; Rui Chen; Size Chen; Linlang Guo
Journal:  Cell Death Differ       Date:  2019-11-14       Impact factor: 15.828

Review 3.  Significance of alternative splicing in cancer cells.

Authors:  Fei Qi; Yong Li; Xue Yang; Yan-Ping Wu; Lian-Jun Lin; Xin-Min Liu
Journal:  Chin Med J (Engl)       Date:  2020-01-20       Impact factor: 2.628

4.  Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer.

Authors:  Rui Li; Stephanie L Ong; Linh M Tran; Zhe Jing; Bin Liu; Stacy J Park; Zi Ling Huang; Tonya C Walser; Eileen L Heinrich; Gina Lee; Ramin Salehi-Rad; William P Crosson; Paul C Pagano; Manash K Paul; Shili Xu; Harvey Herschman; Kostyantyn Krysan; Steven Dubinett
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

5.  High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer.

Authors:  Guanming Deng; Xiaofang Zhou; Le Chen; Ying Yao; Junjun Li; Yun Zhang; Chenhui Luo; Lijuan Sun; Jie Tang
Journal:  Cancer Cell Int       Date:  2020-05-19       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.